|
|
GovernmentDocs 5/4/2008 | 0 (0) | 12 | 0 | 0 | English
Contains Nonbinding RecommendationsGuidance for Industry, FDA Staff, and FDA-Accredited Third PartiesRequests for Inspection by an Accredited Person under the Inspection by Accredited Persons ... more>>
FDADocs 5/9/2008 | 0 (0) | 10 | 0 | 0 | English
The Inspection is Over ??? What Happens Next? Possible FDA Enforcement ActionsPatricia HolobaughFDA Center for Biologics Evaluation and Research Division of Inspections and SurveillanceThe ... more>>
FDADocs 5/9/2008 | 0 (0) | 21 | 0 | 0 | English
FDA/CFSAN/OPA : Agency Response Letter : GRAS Notice No . GRN 000048Page 1 of 3_U. S. Food and Drug Administration Center for Food Safety & Applied NutritionOffice of Premarket ... more>>
FDADocs 5/12/2008 | 0 (0) | 21 | 0 | 0 | English
Exposure-Response: Application to Antimicrobial Drug DevelopmentIDSA/PhRMA/FDA Workshop November... Pharmacology and Biopharmaceutics IDSA/PhRMA/FDA Workshop 11/19/02Guidances: Exposure-Response (E-R ... more>>
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
Improvement in Dose Selection: FDA PerspectiveIDSA/ISAP/FDA Workshop April 16, 2004Jenny J Zheng, Ph.D. Pharmacometrician DPEIII/OCPB/CDER/FDAOffice of Clinical Pharmacology and ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 43 | 0 | 0 | English
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance... document contact Sally Hojvat, Ph.D., at 240-276-0496 or by email at sally.hojvat@fda.hhs.gov.U.S ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 19 | 0 | 0 | English
Prescription Drug User Fee Act III ??? Initiatives & EvaluationsContract No. 223-04-8100 Task No. T1Independent Evaluation of FDA???s First Cycle Review Performance ??? Retrospective Analysis ... more>>
FDADocs 5/5/2008 | 0 (0) | 8 | 0 | 0 | English
1Questions and Answers about FDA???s Enforcement Action Against Unapproved Timed-Release Guaifenesin ProductsWhat action is FDA taking concerning timed-release drug products containing ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 27 | 0 | 0 | English
Draft Guidance for Industry and FDA Staff Modifications to Devices Subject to Premarket Approval (PMA) ??? The PMA Supplement Decision-Making ProcessDRAFT GUIDANCEThis guidance document is being ... more>>
|